OpenAI AI Agent Swarm Behind Hugging Face Hack 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Street Poller Media and The Boom of the Street Interview Ad Industry 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Toyota Global Sales Fall as China Demand Slumps 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Add as a preferred source on Google
OXFORD, United Kingdom, and CAMBRIDGE, Mass., April 05, 2018 -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces that Glyn Edwards, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference on 10 April 2018 at 3:00pm CEST in Monte Carlo, Monaco.
A live audio webcast of the presentation will be available through the Investors section on the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation.
About Summit Therapeutics
Summit is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection. Further information is available at www.summitplc.com and Summit can be followed on Twitter (@summitplc).
For more information, please contact:
| Summit | ||
| Glyn Edwards / Richard Pye (UK office) | Tel: | 44 (0)1235 443 951 |
| Erik Ostrowski / Michelle Avery (US office) | +1 617 225 4455 | |
| Cairn Financial Advisers LLP (Nominated Adviser) | Tel: | +44 (0)20 7213 0880 |
| Liam Murray / Tony Rawlinson | ||
| N+1 Singer (Joint Broker) | Tel: | +44 (0)20 7496 3000 |
| Aubrey Powell / Jen Boorer | ||
| Panmure Gordon (Joint Broker) | Tel: | +44 (0)20 7886 2500 |
| Freddy Crossley, Corporate Finance | ||
| Tom Salvesen, Corporate Broking | ||
| MacDougall Biomedical Communications (US) | Tel: | +1 781 235 3060 |
| Karen Sharma | [email protected] | |
| Consilium Strategic Communications (UK) | Tel: | +44 (0)20 3709 5700 |
| Mary-Jane Elliott / Jessica Hodgson / | [email protected] | |
| Philippa Gardner |
